Showing results (81-90 of 468) with videos related to
Sort By:
Pageof 47
Cancer Chemotherapy and Pharmacology|October 24, 2018
Safety of trifluridine/tipiracil in an open-label expanded-access program in elderly and younger patients with metastatic colorectal cancerRobert J Mayer, Howard S Hochster, Steven J Cohen, et al.The Oncologist|May 14, 2014
Optimizing treatment outcomes with regorafenib: personalized dosing and other strategies to support patient careAxel Grothey, Suzanne George, Eric van Cutsem, et al.Cancer Research|January 25, 2003
Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancerThomas Mueller, Wieland Voigt, Heike Simon, et al.Cancer Management and Research|May 12, 2017
Patient and physician preferences for anticancer drugs for the treatment of metastatic colorectal cancer: a discrete-choice experimentJuan Marcos González, Sarika Ogale, Robert Morlock, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Evaluation of alternate categorical tumor metrics and cut points for response categorization using the RECIST 1.1 data warehouseSumithra J Mandrekar, Ming-Wen An, Jeffrey Meyers, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2008
Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE)Axel Grothey, Mary M Sugrue, David M Purdie, et al.Endocrinology|September 4, 2021
Endoxifen, an Estrogen Receptor Targeted Therapy: From Bench to BedsideSwaathi Jayaraman, Joel M Reid, John R Hawse, et al.Contemporary Clinical Trials Communications|December 25, 2019
Missing tumor measurement (TM) data in the search for alternative TM-based endpoints in cancer clinical trialsMing-Wen An, Jun Tang, Axel Grothey, et al.Cancer|July 30, 2011
Exploring racial differences in outcome and treatment for metastatic colorectal cancer: results from a large prospective observational cohort study (BRiTE)Blase N Polite, Amy Sing, Daniel J Sargent, et al.Cancers|July 12, 2025
Anti-Neoplastic Activity of Estrogen Receptor Beta in Chemoresistant Triple-Negative Breast CancerXiyin Wang, Michael J Emch, Matthew P Goetz, et al.Pageof 47